Bernd Kowall

Bernd Kowall Priv.-Doz. Dr. rer.nat. Dr. rer.san.

Tel.:+ 49 201 / 92239 295
Fax: +49 201 / 92239 333

Bernd.Kowall[at]uk-essen.de
   
 

Curriculum vitae

 

Beruflicher und wissenschaftlicher Werdegang

2017 Habilitation im Fach Epidemiologie
2015 Ruf auf eine W2-Professur an der Hochschule Fulda abgelehnt
Seit 9 / 2014 Wissenschaftlicher Mitarbeiter am IMIBE
1 / 2009 – 8 / 2014 Wissenschaftlicher Mitarbeiter am Institut für Biometrie und Epidemiologie am Deutschen Diabetes Zentrum in Düsseldorf
12/2005 – 10 / 2008 Wissenschaftlicher Mitarbeiter am Lehrstuhl für Epidemiologie und International Public Health an der Universität Bielefeld
Promotion zum Dr.rer.san. an der Universität Düsseldorf (Thema: „Prädiktion und Prognose des Typ-2 Diabetes: Ergebnisse der populationsbasierten KORA S4/F4 Kohortenstudie“)
Promotion zum Dr.rer.nat. an der Universität Dortmund (Thema: „Untersuchungen zur Diederwinkelabhängigkeit vicinaler 119Sn119Sn-Kopplungen sowie neue Palladium-katalysierte Bisstannylierungen“)
Studium der Epidemiologie an der Universität Bielefeld (M.Sc.)
Studium der Sozialwissenschaften an der Fernuniversität Hagen (Magister Artium)
Studium der Chemie an der Universität Dortmund (Dipl.-Chem.)

 

Forschungsschwerpunkte/Projekte

Epidemiologie des Typ-2 Diabetes

Publikationen:

Erstautorschaften (mit Peer Review)


1. Kowall B, Erbel R, Moebus S, Lehmann N, Kröger K, Stang A. Decline in ankle-brachial index is stronger in poorly than in well controlled diabetes: Results from the Heinz Nixdorf Recall Cohort Study. Atherosclerosis 2019 (zur Publikation angenommen)

2. Kowall B, Rathman W, Bongaerts B, Kuss O, Stang A, Roden M, Herder C, Koenig W, Huth C, Heier M, Thorand B, Ladwig KH, Holle R, Meisinger C, Peters A. Incidence rates of type 2 diabetes in people with impaired fasting glucose (ADA vs. WHO Criteria) and impaired glucose tolerance: Results from an older population (KORA S4/F4/FF4 Study). Diabetes Care 2019; 42(2):e18-e20.

3. Kowall B, Lehmann N, Mahabadi AA, Moebus S, Erbel R, Jöckel KH, Stang A. Associations of metabolically healthy obesity with prevalence and progression of coronary artery calcification: Results from the Heinz Nixdorf Recall Cohort Study. Nutr Metab Cardiovasc Dis 2018 (zur Publikation angenommen)

4. Kowall B, Jöckel KH, Stang A. Lungenkrebsscreening: Aktuelle Entwicklungen. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2018; 61: 1551-1558.

5. Kowall B. HbA1c target goals in type-2 diabetes: Novel arguments from measurement of coronary artery calcification. Int J Cardiol 2018; 266: 256-257.

6. Kowall B, Lehmann N, Mahabadi AA, Lehnich AT, Moebus S, Budde T, Seibel R, Grönemeyer D, Erbel R, Jöckel KH, Stang A. Sleep characteristics and progression of coronary artery calcification: Results from the Heinz Nixdorf Recall cohort study. Atherosclerosis 2018; 271: 45-52.

7. Kowall B, Stang A. Fehler und Schwächen in der Berichterstattung über epidemiologische Studien in Printmedien: Das Beispiel „Fleischkonsum und Darmkrebs“. Das Gesundheitswesen 2017; (zur Publikation angenommen)

8. Kowall B, Rathmann W, Stang A, Bongaerts B, Kuss O, Herder C, Roden M, Quante A, Holle R, Huth C, Peters A, Meisinger C. Perceived risk of diabetes seriously underestimates actual diabetes risk: The KORA FF4 study. PLoS One 2017; 12(1):e0171152. doi: 10.1371/journal.pone.0171152.

9. Kowall B, Lehmann N, Mahabadi AA, Moebus S, Budde T, Seibel R, Grönemeyer D, Erbel R, Jöckel KH, Stang A. Progression of coronary artery calcification is stronger in poorly than in well controlled diabetes: Results from the Heinz Nixdorf Recall Study. J Diab Complications 2017; 31: 234-240.

10. Kowall B, Lehnich AT, Erbel R, Moebus S, Jöckel KH, Stang A. Associations between sleep characteristics and weight gain in an older population: Results of the Heinz Nixdorf Recall Study. Nutr Diabetes 2016; 6(8): e225.

11. Kowall B, Stang A. Stolpersteine bei der Interpretation des populationsattributablen Risikos. Das Gesundheitswesen 2018; 80: 149-153.

12. Kowall B, Lehnich AT, Strucksberg KH, Führer D, Erbel R, Jankovic N, Moebus S, Jöckel KH, Stang A. Associations between sleep disturbances, nocturnal sleep duration, daytime napping, and incident prediabetes and type 2 diabetes: the Heinz Nixdorf Recall Study. Sleep Medicine 2016; 21: 35-41

13. Kowall B, Stang A, Rathmann W, Kostev K. No reduced risk of overall, colorectal, lung, breast and prostate cancer with metformin therapy in diabetic patients: Database analyses from Germany and the United Kingdom. Pharmacoepidemiol Drug Saf 2015; 24: 865-874.

14. Kowall B, Rathmann W, Kostev K. Are Sulfonylurea and Insulin Therapies associated with a larger risk of cancer than metformin therapy? A Retrospective Database Analysis. Diabetes Care 2015; 38: 59-65.

15. Kowall B, Holtfreter B, Völzke H, Schipf S, Mundt T, Rathmann W, Kocher T. Pre-diabetes and well-controlled diabetes are not associated with periodontal disease: the SHIP Trend Study. J Clin Periodontol 2015; 42: 422 -430.

16. Kowall B, Breckenkamp J, Berg-Beckhoff G. General practitioners using complementary and alternative medicine differ from general practitioners using conventional medicine in their view of the risks of electromagnetic fields: A postal survey from Germany. J Prim Care Community Health 2015; 6: 21 – 28.

17. Kowall B, Rathmann W, Bongaerts B, Thorand B, Belcredi P, Heier M, Huth C, Rückert I, Stöckl D, Peters A, Meisinger C. Are diabetes risk scores useful for the prediction of cardiovascular diseases? Assessment of seven diabetes risk scores in the KORA S4/F4 cohort study. J Diabetes Complications 2013; 27(4): 340 – 345

18. Kowall B, Rathmann W, Peters A, Thorand B, Meisinger C. Associations between parental longevity and glucose regulation in the offspring: Cross-sectional and longitudinal analyses in the KORA S4/F4 Study. Diabetologia 2013; 56: 484-491.

19. Kowall B, Rathmann W, Giani G et al. Random glucose is useful for individual prediction of type 2 diabetes: Results of the Study of Health in Pomerania (SHIP). Prim Care Diabetes 2013; 7: 25-31.

20. Kowall B, Rathmann W, Strassburger K et al. Use of areas under the receiver operating curve (AROCs) and some caveats, Int J Public Health 2013; 58(3): 485 – 488

21. Kowall B, Rathmann W. HbA1c for diagnosis of type 2 diabetes. Is there an optimal cut point to assess high risk of diabetes complications, and how well does the 6.5% cutoff perform? Diabetes Metab Syndr Obes 2013; 29: 477-491

22. Kowall B, Breckenkamp J, Blettner M, Schlehofer B, Schüz J, Berg-Beckhoff G. Determinants and stability over time of perception of health risks related to mobile phone base stations. Int J Public Health 2012; 57: 735-743.

23. Kowall B, Ebert N, Then C, Thiery J, König W, Meisinger C, Rathmann W, Seissler J. Associations between blood glucose and carotid intima-media thickness disappear after adjustment for shared risk factors: the KORA F4 study. PLoS One 2012; 7(12): e52590. Doi 10.1371.

24. Kowall B, W Rathmann, M Heier, R Holle, A Peters, B Thorand, C Herder, K Strassburger, G Giani, C Meisinger. Impact of weight and weight change on normalization of prediabetes and on persistence of normal glucose tolerance in an older population: the KORA S4 / F4 study. Int J Obesity 2012; 36: 826-833.

25. Rathmann W*, Kowall B*, Tamayo T, Giani G, Holle R, Thorand B, Heier M, Huth C, Meisinger C. Hemoglobin A1c and glucose criteria identify different subjects as having type 2 diabetes in middle-aged and older populations: The KORA S4/F4 Study. Ann Med. 2012; 44: 170 – 177.
*geteilte Erstautorenschaft

26. Kowall B, W Rathmann, M Heier, G Giani, A Peters, B Thorand, C Huth, A. Icks, C Meisinger. Categories of glucose tolerance and continuous glycemic measures and mortality. Eur J Epidemiol 2011; 26: 637 – 645.

27. Kowall B, Rathmann W, Landgraf R. Is HbA1c a valid and feasible tool for the diagnosis of diabetes? Diab Res Clin Prac 2011; 93: 314 - 316.

28. Kowall B, Rathmann W, Strassburger K, Meisinger C, Holle R, Mielck A. Socioeconomic status is not associated with type 2 diabetes incidence in an elderly population in Germany: KORA S4/F4 Cohort Study. J Epidemiol Community Health. 2011; 65(7): 606-12.

29. Kowall B, Rathmann W, Strassburger K, Heier M, Holle R, Thorand B, Giani G, Peters A, Meisinger C. Association of passive and active smoking with incident type 2 diabetes mellitus in the elderly population: the KORA S4/F4 cohort study. Eur J Epidemiol. 2010; 25(6): 393-402.

30. Kowall B, Breckenkamp J, Heyer K, Berg-Beckhoff G. German wide cross sectional survey on health impacts of electromagnetic fields in the view of general practitioners. Int J Public Health. 2010; 55(5): 507-512.

31. Rathmann W*, Kowall B*, Heier M, Herder C, Holle R, Thorand B, Strassburger K, Peters A, Wichmann HE, Giani G, Meisinger C. Prediction models for incident Type 2 diabetes mellitus
in the older population: KORA S4/F4 cohort study. Diabet Med. 2010; 27(10): 1116-1123.
*geteilte Erstautorenschaft


Koautorschaften mit Peer Review


32. Meisinger C, Bongaerts BWC, Heier M, Amann U, Kowall B, Herder C, Rückert-Eheberg IM , Rathmann W, Ziegler D. Pharmacoepidemiol Drug Saf 2018; 27: 806-814.

33. Gülker JE, Kröger J, Kowall B, Dingelstadt M, Stang A. Increasing Use of Anticoagulants in Germany and Ist Impact on Hospitalization for Intracranial Bleeding. Circ Cardiovasc Qual Outcomes 2018; 11:e004470.

34. Kebede TG, Pink C, Rathmann W, Kowall B, Völzke H, Petersmann A, Meisel P, Dietrich T, Kocher T, Holtfreter B. Diabetes Metab 2018; 44: 243-249.

35. Lehnich AT, Kowall B, Kuß O, Schmidt-Pokrzywniak A, Weinreich G, Dragono N, Moebus S, Erbel R, Jöckel KH, Stang A. Do patients with intake of drugs labelled as sleep disturbing actually sleep worse? A population basesd assessment from the Heinz Nixdorf Recall Study. Br J Clin Pharmocol 2016; 82: 869-877.

36. Herder C, Ouwens M, Carstensen M, Kowall B, Huth C, Meisinger C, Rathmann W, Roden M, Thorand B. Adiponectin may mediate the association between omentin, circulating lipids and insulin sensitivity: results from the KORA F4 study. Eur J Endocrinol 2015; 172: 423 – 432.

37. Bongaerts B, Ziegler D, Shaw JE, Heier M, Kowall B, Herder C, Roden M, Peters A, Meisinger C, Rathmann W. A clinical screening score for diabetic polyneuropathy: KORA F4 and AusDiab studies. J Diabetes Complications 2015; 29: 44 – 49.

38. Then C, Kowall B, Lechner A, Meisinger C, Heier M, Koenig W, Peters A, Rathmann W, Seissler J. Plasma copeptin is associated with type 2 diabetes in men but not in women in the population-based KORA F4 study. Acta Diabetol 2015; 52: 103 – 112.

39. Herder C, Bongaerts BW, Rathmann W, Heier M, Kowall B, Koenig W, Thorand B, Roden M, Meisinger C, Ziegler D. Differential Association Between Biomarkers of Sublicinal Inflammation and Painful Polyneuropathy: Results From the KORA F4 Study. Diabetes Care 2015; 38: 91 – 96.

40. Stang A, Kowall B, Rusner C, Trabert B, Bray F, Schüz J, McGlynn KA, Kuss O. A novel method for identifying settings for well-motivated ecologic studies of cancer. Int J Cancer, 2015 (zur Publikation angenommen)

41. Stang A, Schuler M, Kowall B, Darwiche K, Kühl H, Jöckel KH. Lung Cancer Screening Using Low Dose CT Scanning in Germany. Extrapolation of Results from the National Lung Screening Trial. Dtsch Arztebl Int 2015; 112: 637 - 644

42. Herder C, Kowall B, Tabak A, Rathmann W. The potential of novel biomarkers to improve risk prediction of type 2 diabetes. Diabetologia 2014; 57: 16-29

43. Berg-Beckhoff G, Breckenkamp J, Larsen P, Kowall B. General practitioners´ knowledge and concern about electromagnetic fields. Int J Environ Res Public Health 2014; 11: 12696 – 12982.

44. Bongaerts BW, Rathmann W, Heier M, Kowall B, Herder C, Stöckl D, Meisinger C, Ziegler D. Older subjects with diabetes and prediabetes are frequently unaware of having distal sensorimotor polyneuropathy: The KORA F4 Study. Diabetes Care 2013; 36: 1141-1146

45. Wagner R, Thorand B, Osterhoff MA, Müller G, Böhm A, Meisinger C, Kowall B, Rathmann W, Kronenberg F, Staiger H, Stefan N, Roden M, Schwarz PE, Pfeiffer AF, Häring HU, Fritsche A. Family history of diabetes is associated with higher risk for prediabetes: a multicentre analysis from the German Center for Diabetes Research. Diabetologia 2013; 56: 2176-2180.

46. Then C, Kowall B, Lechner A, Meisinger C, Heier M, König W, Peters A, Thiery J, Rathmann W, Seissler J. Plasma Copeptin Levels are inversely associated with Intima-Media-Thickness in Men: The Population-based KORA F4 Study. Cardiovascular Diabetology 2013; 12: 168

47. Herder C, Bongaerts BW, Rathmann W, Heier M, Kowall B, Koenig W, Thorand B, Roden M, Meisinger C, Ziegler D. Association of Subclinical Inflammation With Polyneuropathy in the Older Population: KORA F4 study. Diabetes Care 2013; 36: 3663 – 3670

48. Then C, Kowall B, Lechner A, Meisinger C, Heier M, Koenig W, Peters A, Thiery J, Rathmann W, Seissler J. Plasma MR-proANP levels are associated with carotid intima-media thickness in the general community: the KORA F4 study. Atherosclerosis 2013; 230: 235-241

49. Brinks R, Tamayo T, Kowall B et al. Prevalence of type 2 diabetes in Germany in 2040: estimates from an epidemiological model. Eur J Epidemiol 2012; 27: 791-797.

50. Bongaerts BW, Rathmann W, Kowall B, Herder C, Stöckl D, Meisinger C, Ziegler D. Postchallenge hyperglycemia is positively associated with diabetic polyneuropathy: the KORA F4 study. Diabetes Care 2012; 35: 1891-1893

51. Abbasi A, Corpelijn E, Peelen LM, Gansevoort RT, de Jong PE, Gans RO, Rathmann W, Kowall B, Meisinger C, Hillege HL, Stolk RP, Navis G, Beulens JW, Bakker SJ. External validation of the KORA S4/F4 prediction models for the risk of developing type 2 diabetes in older adults: the PREVEND study. Eur J Epidemiol 2012; 27: 47-52.

52. Seissler J, Feghelm N, Then C, Meisinger C, Herder C, Koenig W, Peters A, Roden M, Lechner A, Kowall B, Rathmann W. Vasoregulatory peptides pro-endothelin-1 and pro-adrenomedullin are associated with metabolic syndrome in the population-based KORA F4 study. Eur J Endocrinol 2012; 167: 847-853.

53. Stöckl D, Doring A, Peters A, Thorand B, Heier M, Huth C, Stöckl H, Rathmann W, Kowall B, Meisinger C (2012). Age at menarche is associated with prediabetes and diabetes in women (aged 32-81 years) from the general population: the KORA F4 Study. Diabetologia 2012; 55: 681-688.

54. Meisinger C, Doring A, Stockl D, Thorand B, Kowall B, Rathmann W. Uric acid is more strongly associated with impaired glucose regulation in women than in men from the general population: the KORA F4-Study. PLoS One 2012; 7 (5), p e37180

55. Rathmann W, Kowall B, Giani G. Type 2 diabetes: unravelling the interaction between genetic predisposition and lifestyle. Diabetologia 2011; 54: 2217 – 2219.

56. Hivert MF, Sullivan LM, Shrader P, Fox CS, Nathan DM, D’Agostino Sr. RB, Wilson PWF, Kowall B, Herder C, Meisinger, Thorand B, Rathmann W, Meigs JB. Insulin resistance influences the association of adiponectin levels with diabetes incidence in two population-based cohorts: KORA S4/F4 Study and Framingham Offspring Study. Diabetologia 2011; 54 (5): 1019-24.

57. Stöckl D, Meisinger C, Peters A, Thorand B, Huth C, Heier M, Rathmann W, Kowall B, Stockl H, Doring A (2011): Age at menarche and its association with the metabolic syndrome and its components: results from the KORA F4 study. PLoS One 2011; 6 (10), p e26076

58. Meisinger C, Rückert IM, Rathmann W, Döring A, Thorand B, Huth C, Kowall B, Koenig W. Retinol-binding protein 4 is associated with prediabetes in adults from the general population: the Cooperative Health Research in the Region of Augsburg (KORA) F4 Study. Diabetes Care 2011; 34: 1648 – 1650.

59. Berg-Beckhoff G, Heyer K, Kowall B, Breckenkamp J, Razum O. The views of primary care physicians on health risks from electromagnetic fields. Dtsch Arztebl Int. 2010; 107(46): 817-23.

60. Berg-Beckhoff G, Blettner M, Kowall B, Breckenkamp J, Schlehofer B, Schmiedel S, Bornkessel C, Reis U, Potthoff P, Schüz J. Mobile phone base stations and adverse health effects: phase 2 of a cross-sectional study with measured radio frequency electromagnetic fields. Occup Environ Med. 2009; 66(2): 124-130.

61. Blettner M, Schlehofer B, Breckenkamp J, Kowall B, Schmiedel S, Reis U, Potthoff P, Schüz J, Berg-Beckhoff G. Mobile phone base stations and adverse health effects: phase 1 of a population-based, cross-sectional study in Germany. Occup Environ Med. 2009; 66 (2): 118-123.


Erstautorschaften (ohne Peer Review)


62. Kowall B, Rathmann W. Methodische Entwicklung von Scores am Beispiel des Diabetes. Der Diabetologe. Sonderheft „Risikoscores“ 2014. (im Druck)

63. Kowall B, Rathmann W, Landgraf R. Einsatz von Risikoscores für den Typ-2-Diabetes in der Praxis. Der Diabetologe. Sonderheft „Risikoscores“ 2014. (im Druck)

64. Kowall B, Rathmann W. Prevention of type 2 diabetes: selection criteria. Diapedia (2013). http://www.diapedia.org/type-2-diabetes-mellitus/prevention-of-t2dm-selection-criteria.

65. Kowall B, Rathmann W. Konsequenzen eines Wechsels von Glukose- zu HbA1c-basierten Kriterien für die Diabetesdiagnose: Ein narratives Review aus epidemiologischer Sicht. Diabetologie und Stoffwechsel 2011; 6: 32-42.

66. Kowall B, Meisinger C, Rathmann W. Ein neu entwickelter Risiko-Score zur Prädiktion des Typ 2-Diabetes in der älteren Bevölkerung. Der Diabetologe 2010; 6: 510-512.

67. Kowall B, Mielck A. Soziale Ungleichheit und Diabetes. Trifft es Arme öfter? Der Diabetologe 2010; 6: 196 – 202.

68. Kowall B. Integrierte evidenzgestützte Bewertung von Public-Health-Maßnahmen. In: A. Gerhardus, J Breckenkamp, O Razum, N Schmacke, H Welzel (Hrsg.): Evidence-based Public Health 2010, S. 119 – 127.


Koautorschaften ohne Peer Review


69. Stang A, Kowall B, Schuler M, Jöckel KH. Früherkennung von Lungenkrebs. Low-Dose-Computertomographie-Screening. Der Onkologe 2016 (zur Publikation angenommen)

70. Schulze MB, Kowall B, Rathmann W. Biomarker und Risikoprädiktion des Typ-2-Diabetes. Der Diabetologe 2012; 8: 18-25.

71. Landgraf R, Kowall B, Rathmann W. HbA1c – ein Alleskönner? Messinstrument zur Therapiekontrolle, zum Screening und zur Diagnose eines Diabetes. Der Diabetologe 2011; 7: 335-346

72. Berg-Beckhoff G, Kowall B, Breckenkamp J (2011). Radio frequency electromagnetic fields: Health effects. In: Nriagu JO (ed.) Encyclopedia of Environmental Health, volume 4, pp. 721–727 Burlington: Elsevier.

73. Rathmann W, Kowall B, Schulze MB. Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort: response to Kolberg et al. Diabetes Care. 2010; 33(2):e28.

74. Breckenkamp J, Blettner M, Kowall B, Schüz J, Schlehofer B, Schmiedel S, Bornkessel C, Reis U, Potthoff P, Berg-Berghoff G. Ergebnisse einer Querschnittsstudie zum Zusammenhang von elektromagnetischen Feldern von Mobilfunksendeanlagen und unspezifischen gesundheitlichen Beschwerden. Umweltmed Forsch Prax 2010; 15 (3): 159 – 166.

75. Rathmann W, Kowall B, Meisinger C. Epidemiologie des Typ 2 Diabetes in Deutschland. Ergebnisse aus der KORA S4/F4 Kohortenstudie. In: Deutsche Diabetes Stiftung (Hrsg.). Diabetes in Deutschland. Edition Lipp Verlagsgemeinschaft. 1. Aufl. 2010, S. 9 – 22.